Skip to main content
SpringerLink
Log in

Insulin and glucagon therapy of acute hepatic failure

  • Conference Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

When insulin and glucagon are administered to rats with severe liver injury, survival is enhanced with an attenuation of the liver injury compared to that of untreated controls. In rats with acute liver injury both hormones produce a rapid normalization of hepatic protein content following initiation of DNA synthesis. When rats receive both hormones after partial hepatectomy, the first burst of DNA synthesis reaches a maximum earlier than that seen in controls. Both hormones enhance the increment of hepatic putrescine essential for DNA synthesis through activation of ornithine decaroxylase and/or spermidine-N1-acetyltransferase. The enhancement of putrescine content by each hormone is additive. Putrescine supplementation promotes hepatic DNA synthesis after hepatectomy. Based on these data, we conclude that a combination of insulin, and glucagon is effective in the therapy of acute hepatic failure in rats. The restoration of liver function as well as the stimulation of liver cell proliferation via putrescine production may contribute to this effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Starzl TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH, Putnam CW: The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 137:179–199, 1973

    Google Scholar 

  2. Starzl TE, Porter KA, Putnam CW: Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet 2:1241–1242, 1975

    Google Scholar 

  3. Starzl TE, Porter KA, Watanabe K, Putnam CW: Effects of insulin, glucagon, and insulin/glucagon infusions on liver morhology and cell division after complete portacaval shunt in dogs. Lancet 1:821–825, 1976

    Google Scholar 

  4. Starzl TE, Porter KA, Kashiwagi N, Lee IY, Russell WJI, Punam CW: The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet 140:549–562, 1977

    Google Scholar 

  5. Bucher NLR, Swaffield MN: Regulation of hepatic regeneration in rats by synergistic action in insulin and glucagon. Proc Natl Acad Sci USA 72:1157–1160, 1975

    Google Scholar 

  6. Whittemore AD, Kasuya M, Voorhees AB Jr, Price JB Jr: Hepatic regeneration in the absence of portal viscera. Surgery 77:1157–1160, 1975

    Google Scholar 

  7. Barra R, Hall JC: Liver regeneration in normal and alloxaninduced diabetic rats. J Exp Zool 201:93–100, 1977

    Google Scholar 

  8. Farivar M, Wands JR, Isselbacher KJ, Bucher NLR: Effect of insulin and glucagon on fulminant murine hepatitis. N Engl J Med 295:1517–1519, 1976

    Google Scholar 

  9. Jaspan JB, Landau RL, Schneider J: Insulin and glucagon infusion in the treatment of liver failure. Arch Intern Med 144:2075–2078, 1984

    Google Scholar 

  10. Baker AL, Jaspan JB, Haines NW, Hatfield GE, Krager PS, Schneider JF, the University of Chicago Medical House Staff: A randomized clinical trial of insulin and glucagon infusion for the treatment of alcoholic hepatitis: Progress report in 50 patients. Gastroenterology 80:1410–1414, 1981

    Google Scholar 

  11. Radvan G, Kanel G, Redeker A: Insulin and glucagon infusion in acute alcoholic hepatitis. Gastroenterology 82:1154, 1982

    Google Scholar 

  12. Feher J, Cornides A, Romany A, Karteszi M, Szalay L, Gogl A, Picazo J: A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis. J Hepatol 5:224–231, 1987

    Google Scholar 

  13. Okita K, Matsuda S, Hata K, Morimoto T, Sasaki M, Fukumoto Y, Kodama T, Takemoto T: Clinical use of glucagon and insulin in therapy of fulminant hepatic failure. Gastroenterol Jpn 14:453–457, 1979

    Google Scholar 

  14. Okita K, Masuda S, Hanta H, Yasunaga M, Sanuki K, Takemoto T: Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis. Gastroenterol Jpn 22:603–613, 1987

    Google Scholar 

  15. Oka H, Okita K, Fujiwara K: Glucagon and insulin therapy in fulminant hepatic failure in Japan.In Glucagon in Gastroenterology and Hepatology. Pharmacological, Clinical and Therapeutic Implications. J Picazo (ed). Lancaster, MTP Press, 1982, pp 171–180

    Google Scholar 

  16. Oka H, Fujiwara K, Okita K, Ishii H, Sakuma A: A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepetitis. Gastroenterol Jpn 24:332–336, 1989

    Google Scholar 

  17. Fujiwara K, Ogata I, Oka H: Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: Analysis of a double blind controlled trial. Gastroenterol Jpn, 24:143–148, 1989

    Google Scholar 

  18. Magee PN: Cellular injury and alkylation of cell components. CIBA Foundation Symposium in Cellular Injury. US de Reuk, J Knight (eds). Boston, Little Brown, 1964, pp 1–22

    Google Scholar 

  19. Fujiwara K, Ogata I, Mishiro S, Ohta Y, Oka Y, Takatsuki K, Sato Y, Hayashi S, Yamada S, Oka H: Glucagon and insulin for the treatment of hepatic failure in dimethylnitrosamine-intoxicated rats. Scand J Gastroenterol 23:567–573, 1988

    Google Scholar 

  20. Masaki N, Yamada S, Ogata I, Ohta Y, Fujiwara K: Enhancement of carbon tetrachloride-induced liver injury by glucagon and insulin treatment. Res Exp Med 188:27–33, 1988

    Google Scholar 

  21. Takatsuki K, Fujiwara K, Hayashi S, Ota Y, Torii M, Mishiro S, Ogata I, Sakuma A, Oka H, Oda T: Acceleration of DNA synthesis in post-hepatectomized regenerating liver of normal rat by insulin and glucagon. Life Sci 29:2609–2615, 1981

    Google Scholar 

  22. De Diego JA, Molita LM, Bujan J, Simon P, Gea M, Menchero A, Balibrea JL: Influence of the conjoint administration of insulin and glucagon upon hepatic regeneration. Surg Gynecol Obstet 163:443–447, 1986

    Google Scholar 

  23. Schrock TR, Oakman NJ, Bucher NLR: Ornithine decarboxylase activity in relation to growth of rat liver. Effects of partial hepatectomy, hypertonic infusions, celite injection or other stressful procedures. Biochim Biophys Acta 204:564–577, 1970

    Google Scholar 

  24. Thrower S, Ord MG: Hormonal control of liver regeneration. Biochem J 144:361–369, 1974

    Google Scholar 

  25. Matsui I, Pegg AE: Effect of thioacetamide, growth hormone or partial hepatectomy on spermidine acetyltransferase activity of rat liver cytosol. Biochim Biophys Acta 633:87–94, 1980

    Google Scholar 

  26. Matsui I, Wiegand L, Pegg AE: Properties of spermidine-N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. J Biol Chem 256:2454–2459, 1981

    Google Scholar 

  27. Poso H, Pegg AE: Effect of carbon tetrachloride on polyamine metabolism in rodent liver. Arch Biochem Biophys 217:730–737, 1982

    Google Scholar 

  28. Holtta E: Oxidation of spermidine in rat liver: Purification and properties of polyamine oxidase. Biochemistry 16:91–100, 1977

    Google Scholar 

  29. Sato Y, Fujiwara K: Compensatory route of spermidine acetylation and oxidation can supply sufficient putrescine for hepatic DNA synthesis at an early stage after partial hepatectomy in diaminopropane-treated rats. J Biol 104:98–191, 1988

    Google Scholar 

  30. Sato Y, Fujiwara K, Ogata I, Tomiya T, Oka H: Additive stimulation of hepatic putrescine production by glucagon and insulin after partial hepatectomy in rats. Life Sci 41:77–83, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan

    K. Fujiwara, I. Ogata, Y. Sato, T. Tomiya, Y. Ohta, Y. Oka, S. Nagoshi, S. Yamada, N. Masaki, K. Takatsuki, S. Hayashi & H. Oka

Authors
  1. K. Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Ogata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Tomiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Ohta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y. Oka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Nagoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N. Masaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K. Takatsuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S. Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. H. Oka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujiwara, K., Ogata, I., Sato, Y. et al. Insulin and glucagon therapy of acute hepatic failure. Digest Dis Sci 36, 809–815 (1991). https://doi.org/10.1007/BF01311241

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01311241

Key Words

Search

Navigation